Earnings

Walmart stock price target reset by JPMorgan after earnings

Walmart just handed Wall Street a mixed bag. 

Despite rising revenue and profits, shares of the big-box retailer fell more than 9%, following its recent quarterly results. 

Soon after, JPMorgan adjusted its stock price target for Walmart (WMT). 

Walmart stock price target drops to $125

At the time of writing, WMT stock trades around $104. Valued at a market cap of $825 billion, Walmart has returned more than 400% to shareholders over the past decade, after adjusting for dividend reinvestments. 

The stock’s decade-long outperformance has meant it trades at 35x forward earnings, which is steep for a company projected to grow earnings at a compounded annual rate of 8.7% over the next five years.

Related: Walmart shoppers must consider one major shift coming to prices

By comparison, Walmart’s 10-year average P/E multiple is much lower at 25x. 

According to Investing.com:

  • JPMorgan lowered its price target on Walmart to $125 from $137, while maintaining its “Overweight” rating on the blue-chip stock.

  • JPMorgan had already cut its same-store sales estimate for Walmart three weeks before earnings. When the actual number landed, it came in below the lowered projection. 

  • The analyst described the setup heading into results as a “hairball,” a messy tangle of moving pieces that made the stock hard to call. 

Why Walmart stock is under pressure

Walmart’s health and wellness business has weighed on revenue and margins in fiscal Q2 of 2027 (ended in July). 

Walmart’s chief financial officer, John David Rainey, told analysts on the company’s second-quarter fiscal 2027 earnings call that new maximum fair pricing regulation impacted total comparable sales by 125 basis points in the quarter, worse than the 100 basis point hit the company had planned for entering the year.

Walmart U.S. comparable sales came in at 2.6% for the quarter. Strip out health and wellness, and that number looks a lot healthier, closer to the 3% to 4% range the company has posted consistently over the past two and a half years. 

CEO John Furner called it a good quarter overall, with sales growth at the top end of guidance and adjusted operating income up 17.4% in constant currency. 

Furner said the pharmacy headwind masked otherwise strong performance across grocery, general merchandise and e-commerce.

John Furner, CEO, Walmart, expects new revenue streams to drive growthPaul Morigi/Getty Images

Walmart C-suite looks beyond pharmacy drag

JPMorgan’s keeping an outperform rating while cutting its short term price target rests on a simple idea. Walmart has more ways to make money than it used to, and those newer businesses are growing fast enough to offset the pharmacy drag.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button